drugset / Trial / NCT02638051

Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT

NCT02638051 ↗

Phase 2 Completed 260 enrolled Galenic Research Institute Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial studies efficacy and safety of combination of modulated electro-hyperthermia (mEHT) with Traditional Chinese Medicine (TCM) in treatment of peritoneal carcinomatosis with malignant ascites versus standard chemoinfusion (CDDP+5FU).

Timeline

Start
2014-01
Primary completion
2014-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified 30 mg Other
Comparator Cisplatin Other / unclassified 60 mg Other
Comparator fluorouracil Small molecule 500 mg/m2 Other
Comparator fluorouracil Small molecule 600 mg/m2 Other